NCI-NCL Annual Report
The Nanotechnology Characterization Laboratory (NCL) was founded by the National Cancer Institute (NCI) in 2004, in collaboration with the FDA and NIST, as part of a public-private partnership to advance the science needed to accelerate the development of promising nanotechnology therapies and diagnostics. The NCL, part of the Frederick National Laboratory for Cancer Research (FNLCR), has tested more than 500 nanomaterials, including...